190 related articles for article (PubMed ID: 21642537)
21. TRPP2: Ca2+-permeable cation channel and more.
Giamarchi A; Padilla F; Crest M; Honore E; Delmas P
Cell Mol Biol (Noisy-le-grand); 2006 Dec; 52(8):105-14. PubMed ID: 17535744
[TBL] [Abstract][Full Text] [Related]
22. TRPP2 ion channels: The roles in various subcellular locations.
Tian PF; Sun MM; Hu XY; Du J; He W
Biochimie; 2022 Oct; 201():116-127. PubMed ID: 35760123
[TBL] [Abstract][Full Text] [Related]
23. Molecular advances in autosomal dominant polycystic kidney disease.
Gallagher AR; Germino GG; Somlo S
Adv Chronic Kidney Dis; 2010 Mar; 17(2):118-30. PubMed ID: 20219615
[TBL] [Abstract][Full Text] [Related]
24. Novel PKD1 and PKD2 mutations in autosomal dominant polycystic kidney disease (ADPKD).
Hoefele J; Mayer K; Scholz M; Klein HG
Nephrol Dial Transplant; 2011 Jul; 26(7):2181-8. PubMed ID: 21115670
[TBL] [Abstract][Full Text] [Related]
25. New mutations in the PKD1 gene in Czech population with autosomal dominant polycystic kidney disease.
Stekrova J; Reiterova J; Svobodova S; Kebrdlova V; Lnenicka P; Merta M; Viklicky O; Kohoutova M
BMC Med Genet; 2009 Aug; 10():78. PubMed ID: 19686598
[TBL] [Abstract][Full Text] [Related]
26. Autosomal dominant polycystic kidney disease: comprehensive mutation analysis of PKD1 and PKD2 in 700 unrelated patients.
Audrézet MP; Cornec-Le Gall E; Chen JM; Redon S; Quéré I; Creff J; Bénech C; Maestri S; Le Meur Y; Férec C
Hum Mutat; 2012 Aug; 33(8):1239-50. PubMed ID: 22508176
[TBL] [Abstract][Full Text] [Related]
27. The native TRPP2-dependent channel of murine renal primary cilia.
Kleene SJ; Kleene NK
Am J Physiol Renal Physiol; 2017 Jan; 312(1):F96-F108. PubMed ID: 27760766
[TBL] [Abstract][Full Text] [Related]
28. Cation channel regulation by COOH-terminal cytoplasmic tail of polycystin-1: mutational and functional analysis.
Vandorpe DH; Wilhelm S; Jiang L; Ibraghimov-Beskrovnaya O; Chernova MN; Stuart-Tilley AK; Alper SL
Physiol Genomics; 2002 Feb; 8(2):87-98. PubMed ID: 11875186
[TBL] [Abstract][Full Text] [Related]
29. Role of TRPP2 in mouse airway smooth muscle tension and respiration.
Sang D; Bai S; Yin S; Jiang S; Ye L; Hou W; Yao Y; Wang H; Shen Y; Shen B; Du J
Am J Physiol Lung Cell Mol Physiol; 2019 Oct; 317(4):L466-L474. PubMed ID: 31411061
[TBL] [Abstract][Full Text] [Related]
30. A novel PKD1 variant demonstrates a disease-modifying role in trans with a truncating PKD1 mutation in patients with autosomal dominant polycystic kidney disease.
Ali H; Hussain N; Naim M; Zayed M; Al-Mulla F; Kehinde EO; Seaburg LM; Sundsbak JL; Harris PC
BMC Nephrol; 2015 Mar; 16():26. PubMed ID: 25880449
[TBL] [Abstract][Full Text] [Related]
31. Analysis of the cytoplasmic interaction between polycystin-1 and polycystin-2.
Casuscelli J; Schmidt S; DeGray B; Petri ET; Celić A; Folta-Stogniew E; Ehrlich BE; Boggon TJ
Am J Physiol Renal Physiol; 2009 Nov; 297(5):F1310-5. PubMed ID: 19726544
[TBL] [Abstract][Full Text] [Related]
32. The Structure of the Polycystic Kidney Disease Channel PKD2 in Lipid Nanodiscs.
Shen PS; Yang X; DeCaen PG; Liu X; Bulkley D; Clapham DE; Cao E
Cell; 2016 Oct; 167(3):763-773.e11. PubMed ID: 27768895
[TBL] [Abstract][Full Text] [Related]
33. Identification of Three Novel Frameshift Mutations in the PKD1 Gene in Iranian Families with Autosomal Dominant Polycystic Kidney Disease Using Efficient Targeted Next-Generation Sequencing.
Ranjzad F; Aghdami N; Tara A; Mohseni M; Moghadasali R; Basiri A
Kidney Blood Press Res; 2018; 43(2):471-478. PubMed ID: 29590654
[TBL] [Abstract][Full Text] [Related]
34. Novel mutations of PKD1 gene in Chinese patients with autosomal dominant polycystic kidney disease.
Ding L; Zhang S; Qiu W; Xiao C; Wu S; Zhang G; Cheng L; Zhang S
Nephrol Dial Transplant; 2002 Jan; 17(1):75-80. PubMed ID: 11773467
[TBL] [Abstract][Full Text] [Related]
35. TRPP2 ion channels: Critical regulators of organ morphogenesis in health and disease.
Busch T; Köttgen M; Hofherr A
Cell Calcium; 2017 Sep; 66():25-32. PubMed ID: 28807147
[TBL] [Abstract][Full Text] [Related]
36. Is it Time to Fold the Cysts Away?
Krappitz M; Gallagher AR; Fedeles S
Trends Mol Med; 2016 Dec; 22(12):997-999. PubMed ID: 27793600
[TBL] [Abstract][Full Text] [Related]
37. Predicted Mutation Strength of Nontruncating PKD1 Mutations Aids Genotype-Phenotype Correlations in Autosomal Dominant Polycystic Kidney Disease.
Heyer CM; Sundsbak JL; Abebe KZ; Chapman AB; Torres VE; Grantham JJ; Bae KT; Schrier RW; Perrone RD; Braun WE; Steinman TI; Mrug M; Yu AS; Brosnahan G; Hopp K; Irazabal MV; Bennett WM; Flessner MF; Moore CG; Landsittel D; Harris PC;
J Am Soc Nephrol; 2016 Sep; 27(9):2872-84. PubMed ID: 26823553
[TBL] [Abstract][Full Text] [Related]
38. Genetics May Predict Effectiveness of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease.
Sekine A; Hoshino J; Fujimaru T; Suwabe T; Mizuno H; Kawada M; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Mandai S; Chiga M; Kikuchi H; Ando F; Mori T; Sohara E; Uchida S; Sawa N; Takaichi K; Ubara Y
Am J Nephrol; 2020; 51(9):745-751. PubMed ID: 32784291
[TBL] [Abstract][Full Text] [Related]
39. The diverse effects of pathogenic point mutations on ion channel activity of a gain-of-function polycystin-2.
Wang Y; Wang Z; Pavel MA; Ng C; Kashyap P; Li B; Morais TDC; Ulloa GA; Yu Y
J Biol Chem; 2023 May; 299(5):104674. PubMed ID: 37028763
[TBL] [Abstract][Full Text] [Related]
40. Novel and de novo PKD1 mutations identified by multiple restriction fragment-single strand conformation polymorphism (MRF-SSCP).
Thongnoppakhun W; Limwongse C; Vareesangthip K; Sirinavin C; Bunditworapoom D; Rungroj N; Yenchitsomanus PT
BMC Med Genet; 2004 Feb; 5():2. PubMed ID: 15018634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
